Form 8-K - Current report:
SEC Accession No. 0001437749-22-009755
Filing Date
2022-04-26
Accepted
2022-04-26 16:30:54
Documents
13
Period of Report
2022-04-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dyai20220425_8k.htm   iXBRL 8-K 22451
  Complete submission text file 0001437749-22-009755.txt   157434

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA dyai-20220422.xsd EX-101.SCH 3602
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dyai-20220422_def.xml EX-101.DEF 11920
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE dyai-20220422_lab.xml EX-101.LAB 15967
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dyai-20220422_pre.xml EX-101.PRE 12131
7 EXTRACTED XBRL INSTANCE DOCUMENT dyai20220425_8k_htm.xml XML 2690
Mailing Address 140 INTRACOASTAL POINTE DRIVE SUITE 404 JUPITER FL 33477
Business Address 140 INTRACOASTAL POINTE DRIVE SUITE 404 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Filer) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32513 | Film No.: 22854801
SIC: 2836 Biological Products, (No Diagnostic Substances)